Czechia vs Singapore: Coverage of the human papillomavirus vaccine
Czechia
70
in 2025
Singapore
71
in 2025
Czechia rank
41st
Singapore rank
39th
Coverage of the human papillomavirus vaccine over time
- Czechia
- Singapore
How they compare
Singapore currently reports 71 against 70 in Czechia, a difference of 1.
The two have swapped places 3 times across 12 shared years of data; in 2014 it was Czechia ahead.
Czechia ranks 41st and Singapore ranks 39th of 85 countries.
Czechia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Czechia | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 67.83 | 0.6667 | 67.17 | Czechia |
| 2020s | 68.17 | 65.5 | 2.67 | Czechia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher coverage of the human papillomavirus vaccine, Czechia or Singapore?
- Singapore, at 71 against 70 in Czechia as of 2025.
- What is the difference in coverage of the human papillomavirus vaccine between Czechia and Singapore?
- 1, with Singapore ahead.
- How many years of comparable data are there for Czechia and Singapore?
- 12 years are reported by both, from 2014 to 2025.
- How do Czechia and Singapore rank globally for coverage of the human papillomavirus vaccine?
- Czechia ranks 41st and Singapore ranks 39th of 85 countries.
- Where does this data come from?
- Our World in Data, published as Coverage of the human papillomavirus vaccine. Statizoid refreshes it automatically from the source and publishes the full history for both places.